Leveraging Continuous Glucose Monitors to Reduce the Risk of Diabetic Retinopathy

By sjmartinez • March 7, 2024

Everett EM. Leveraging Continuous Glucose Monitors to Reduce the Risk of Diabetic Retinopathy. JAMA Netw Open. 2024 Mar 4;7(3):e240718. doi: 10.1001/jamanetworkopen.2024.0718. PMID: 38446485.

Tags: Endocrinology, General Internal Medicine, Publications, Veterans Administration

Regular Insulin Versus NPH Insulin for Continuous Enteral Tube Feeding in Hospitalized Patients

Kalangi ST, Bokka SM, Anand S, Garg R. Regular Insulin Versus NPH Insulin for Continuous Enteral Tube Feeding in Hospitalized Patients. Clin Diabetes. 2025 Apr[...]

Real-World Interventions for Type 2 Diabetes Prevention (REALITY): A Multisite Study to Assess the Effectiveness and Cost-Effectiveness of the National Diabetes Prevention Program

Herman WH, Tyndall BD, Duru OK, Moin T, McEwen LN, Shao H, Ackermann RT, Jacobs SR, Neuwahl S, Kuo S, Zhang P, Pavkov ME, Villatoro[...]

Nardilysin in adipocyte regulates insulin sensitivity via HIF1alpha and PPARgamma

Matsuda S, Ohno M, Nishi K, Ikeda S, Iwasaki H, Eifuku T, Hiraoka Y, Kimura T, Ono K, Nishi E. Nardilysin in adipocyte regulates insulin[...]